Cancer Diagnostics Market to Hit 8.8% CAGR Driven by Cancer Imaging Test to 2021

PUNE, India, July 19, 2016 /PRNewswire/ --

According to Global Cancer Diagnostics Market 2016 - 2021 research report, North America and Europe will drive the cancer diagnostic market for next few years with lung, breast, bowel and prostate cancers staying on top as major cause of cancer diagnostics while cancer imaging test would form the largest market segment for cancer diagnosis.

Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market. The report has projected the Global Cancer Diagnostics Market to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, the market has been segmented into four types, namely, imaging tests, endoscopy, biopsy and tumor markers.

Complete report on Global Cancer Diagnostics Market spread across 132 pages, provides 45 data figures is now available at http://www.rnrmarketresearch.com/global-cancer-diagnostics-market-trends-opportunities-and-forecasts-2016-2021-by-type-imaging-tests-endoscopy-biopsy-tumor-marker-by-imaging-tests-sub-type-mri-ultrasound-pet-ct-scan-mammography-by-re-rope-mea-market-report.html.

Cancer diagnostics are used in the basic screening of cancer as well as detailed diagnosis to ascertain the presence of cancer. Multiple tools have been used in the identification of different types of cancer depending upon the symptoms of the patient.

From the market point of view, imaging tests remain the largest segment being driven by its cost effectiveness. However, with growing awareness among the population, early stage screening of cancer is rising, through tumor markers, using which the market for the same will achieve stronger growth. Lung, Breast, Bowel and Prostrate Cancers will remain the major cause of Cancer Diagnostics.

North America region remains the major market followed by Europe in the actual period. APAC holds the major market due to growing middle class population combined with the rise in the per capita healthcare expenditure among the forecasts period.

Company profiling are Abbott Laboratories, Becton Dickinson and Company, F. Hoffmann-La Roche AG (Roche Diagnostics), General Electric Co (General Healthcare), Thermo Fisher Scientific, Agilent Technologies, Inc., Illumina, Inc., Hologic Inc. and C. R. Bard Inc.

The report Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021) - (By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker; By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography; By Region: North America, Latin America, APAC, Europe, MEA) has analysed the potential of Global Cancer Diagnostics Market and provides statistics, information and analysis on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global cancer diagnostics market. Additionally, the report also highlights market entry strategies for various companies across the globe. Order a Copy of Report at http://www.rnrmarketresearch.com/contacts/purchase?rname=633436.

Another report related to cancer and titled Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors: This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic therapeutics cannot cure cancer and yet in 2014, the overall market for cancer therapeutics stood at about $84.3 billion. Any drug that can provide a reasonable survival of more than five years for the cancer patients can achieve a blockbuster status. Within the cancer therapeutics, the immunotherapeutic drugs have gained worldwide acceptance, because they are targeted drugs targeting only the cancer cells. Today, cancer immunotherapy drugs have captured nearly 50% of the overall oncology drugs market, generating about $41.0 billion in 2014 alone. This report describes the evolution of such a huge market in 11 chapters supported by 114 tables and 41 figures over 256 pages. Complete report available at http://www.rnrmarketresearch.com/global-usa-cancer-immunotherapy-market-analysis-to-2020-market-report.html.

Explore other reports on Cancer Diagnostics Market at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/in-vitro-diagnostics-ivd/cancer-diagnostics .

About Us: 

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
sales@rnrmarketresearch.com